-
GSK recalls acetaminophen products that were not child-proofedThe FDA has given special attention to the risks of acetaminophen, the nonaspirin pain reliever found in more than 600 over-the-counter products. While effective in proper doses, take too much and it2014/7/23
-
FDA in search of a new head for its Indian operationsWhen India-born Altaf Lal was named to run theFDAoffice inIndialast year, he pledged to work with Indian drugmakers there to improve quality and their chances of avoiding regulatory actions by the age2014/7/23
-
Gilead litigation says claims by Merck, AbbVie on Sovaldi are patently wrongGilead Sciences got to the market first with an interferon-free oral hepatitis C fighter, a category projected to hit $20 billion in sales by 2020. ItsSovaldihas been racking up unprecedented sales, a2014/7/22
-
Roche CEO: No appetite for expensive megadeals hereNot every drug chief wants to ride the wave of M&A sweeping through pharma. Example: Roche CEOSeverin Schwan, who says he'll stay in the shallows. "We're sticking to our previous strategy," Schwa2014/7/22
-
CFDA Vice Minister Wu Zhen meets CEO of the GAVI AllianceOn July 16, 2014, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by Seth Berkley, CEO of the GAVI Alliance. Both parties had in-depth discussions on t2014/7/21
-
Speech made on WHO's Announcement on the Conclusion of Reassessment on Chinese Vaccine Regulatroy System by Margret Chan, Director General of the World Health OrganizationSpeech on China’s successful nationalregulatory authority re-assessmentBeijing, China, 4 July 2014 Minister Zhang Yong, friends and colleagues, ladies and gentlemen, I have two pieces of very good n2014/7/21
-
Top officials at FDA's India office bolt after less than a yearFDA CommissionerMargaret Hamburg, during her first-ever trip toIndiathis year, urged its drugmakers and regulators to get on board with international quality standards, while promising close cooperati2014/7/18
-
China allows trial of investigators of GSK sex-tape scandal to go publicTwo weeks after raising international concerns by vowing to prosecute private investigator Peter Humphrey and his wife Yu Yingzeng in a closed trial, China has abruptly changed course. Now Humphrey an2014/7/18
-
Novartis sales flag on Diovan generics, but CEO promises cost cuts will fuel profitsTake a look at Novartis' ($NVS) second-quarter results for reasons why it engineered that big asset swap-and-sale with GlaxoSmithKline ($GSK) and Eli Lilly ($LLY). The two units Novartis is unloading,2014/7/17
-
Health Canada approves Sunovion’s Aptiom to treat partial-onset seizures in epilepsy patientsHealth Canada has approved Sunovion Pharmaceuticals Canada's Aptiom, a voltage-gated sodium channel inhibitor, for use as a once-daily adjunctive therapy for treatment of partial-onset seizures in pat2014/7/16